EATG » Betting on hepatitis C: how financial speculation in drug development influences access to medicines

Betting on hepatitis C: how financial speculation in drug development influences access to medicines

Victor Roy and Lawrence King argue that the acquisition strategies of drug companies magnify development costs and leave the public paying twice—for research and high priced medicines

To read the full analysis, click here.

Source:
BMJ
News categories: Hepatitis, Access, R&D